SDC4 and metabolic dysfunction-associated steatotic liver disease: Recently, syndecan-4 was also published to be a serum marker of NAFLD (7) and also acts as a receptor of HCV (57), not only infecting the hepatocytes but also responsible for the submission of the virus from men to men infecting anal Langerhans cells (58).